These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 28674538)
21. CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs. Wang H; Kwak D; Fassett J; Hou L; Xu X; Burbach BJ; Thenappan T; Xu Y; Ge JB; Shimizu Y; Bache RJ; Chen Y Hypertension; 2016 Sep; 68(3):688-96. PubMed ID: 27432861 [TBL] [Abstract][Full Text] [Related]
22. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949 [TBL] [Abstract][Full Text] [Related]
23. Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Goltsman I; Wang X; Lavallie ER; Diblasio-Smith EA; Ovcharenko E; Hoffman A; Abassi Z; Feuerstein GZ; Winaver J Circ Heart Fail; 2011 May; 4(3):345-54. PubMed ID: 21398416 [TBL] [Abstract][Full Text] [Related]
24. [Influence of amlodipine on serum level of some cytokines in patients with congestive heart failure]. Salomon P; Halawa B; Karolko B Pol Arch Med Wewn; 2003 Feb; 109(2):149-55. PubMed ID: 12879778 [TBL] [Abstract][Full Text] [Related]
25. Sodium and water retention in heart failure: pathogenesis and treatment. Martin PY; Schrier RW Kidney Int Suppl; 1997 Jun; 59():S57-61. PubMed ID: 9185106 [TBL] [Abstract][Full Text] [Related]
26. [Pro-inflammatory cytokines in chronic cardiac failure: state of problem]. Korotaeva AA; Samoilova EV; Mindzaev DR; Nasonova SN; Zhirov IV; Tereschenko SN Ter Arkh; 2021 Nov; 93(11):1389-1394. PubMed ID: 36286664 [TBL] [Abstract][Full Text] [Related]
27. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure. Huby AC; Turdi S; James J; Towbin JA; Purevjav E Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650 [TBL] [Abstract][Full Text] [Related]
28. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Gullestad L; Aukrust P Am J Cardiol; 2005 Jun; 95(11A):17C-23C; discussion 38C-40C. PubMed ID: 15925560 [TBL] [Abstract][Full Text] [Related]
29. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-1beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. Roux J; Kawakatsu H; Gartland B; Pespeni M; Sheppard D; Matthay MA; Canessa CM; Pittet JF J Biol Chem; 2005 May; 280(19):18579-89. PubMed ID: 15755725 [TBL] [Abstract][Full Text] [Related]
31. New Insights Into the Role of Inflammation in the Brain in Heart Failure. Badoer E Front Physiol; 2022; 13():837723. PubMed ID: 35309046 [TBL] [Abstract][Full Text] [Related]
32. The role of vitamin D in chronic heart failure. Pourdjabbar A; Dwivedi G; Haddad H Curr Opin Cardiol; 2013 Mar; 28(2):216-22. PubMed ID: 23370227 [TBL] [Abstract][Full Text] [Related]
33. Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system. Teerlink JR J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S1-8. PubMed ID: 8723392 [TBL] [Abstract][Full Text] [Related]
34. Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure. Iskandar R; Liu S; Xiang F; Chen W; Li L; Qin W; Huang F; Chen X Exp Ther Med; 2017 May; 13(5):1850-1858. PubMed ID: 28565777 [TBL] [Abstract][Full Text] [Related]
35. Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure. Mirzoyev Z; Anavekar NS; Chen HH Timely Top Med Cardiovasc Dis; 2005 Apr; 9():E9. PubMed ID: 15830034 [TBL] [Abstract][Full Text] [Related]
36. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy? Werner C; Pöss J; Böhm M Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830 [TBL] [Abstract][Full Text] [Related]
37. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure. Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471 [TBL] [Abstract][Full Text] [Related]
38. Renal and humoral pathophysiological actions of angiotensin II in congestive heart failure. Mirzoyev Z; Anavekar NS; Chen HH Drugs Today (Barc); 2005 Feb; 41(2):129-39. PubMed ID: 15821784 [TBL] [Abstract][Full Text] [Related]
39. Impeded alveolar-capillary gas transfer with saline infusion in heart failure. Guazzi M; Agostoni P; Bussotti M; Guazzi MD Hypertension; 1999 Dec; 34(6):1202-7. PubMed ID: 10601119 [TBL] [Abstract][Full Text] [Related]
40. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]